Author:
Tang Chaoyan,Pang Tianjiao,Dang Chaozhi,Liang Hui,Wu Junfeng,Shen Xiaofang,Wang Lielin,Luo Ruiqiong,Lan Haiyun,Zhang Ping
Abstract
Abstract
Background
The cardiometabolic index (CMI) is a new metric derived from the triglyceride-glucose index and body mass index and is considered a potential marker for cardiovascular risk assessment. This study aimed to examine the correlation between the CMI and the presence and severity of arteriosclerosis in patients with type 2 diabetes mellitus (T2DM).
Methods
This study involved 2243 patients with T2DM. The CMI was derived by dividing the triglyceride level (mmol/L) by the high-density lipoprotein level (mmol/L) and then multiplying the quotient by the waist-to-height ratio. Multivariate logistic regression was used to analyze the correlations between the CMI and BMI blood biomarkers, blood pressure, and brachial-ankle pulse wave velocity (baPWV).
Results
Patients were categorized into three groups based on their CMI: Group C1 (CMI < 0.775; n = 750), Group C2 (CMI: 0.775–1.355; n = 743), and Group C3 (CMI > 1.355; n = 750). Increased BMI, fasting glucose, insulin (at 120 min), total cholesterol (TC), and baPWV values were observed in Groups C2 and C3, with statistically significant trends (all trends P < 0.05). The CMI was positively correlated with systolic blood pressure (r = 0.74, P < 0.001). Multivariate analysis revealed that an increased CMI contributed to a greater risk for arteriosclerosis (OR = 1.87, 95%CI: 1.66–2.10, P < 0.001). Compared to the C1 group, the C2 group and C3 group had a greater risk of developing arteriosclerosis, with ORs of 4.55 (95%CI: 3.57–5.81, P<0.001) and 5.56 (95%CI: 4.32–7.17, P<0.001), respectively. The association was notably stronger in patients with a BMI below 21.62 kg/m² than in those with a BMI of 21.62 kg/m² or higher (OR = 4.53 vs. OR = 1.59).
Conclusions
These findings suggest that the CMI is a relevant and independent marker of arteriosclerosis in patients with T2DM and may be useful in the risk stratification and management of these patients.
Funder
Scientific Research and Technology Development Program of Yulin City
Publisher
Springer Science and Business Media LLC
Reference24 articles.
1. Artasensi A, Pedretti A, Vistoli G, et al. Type 2 diabetes Mellitus: a review of Multi-target drugs. Molecules. 2020;25(8). https://doi.org/10.3390/molecules25081987. [published Online First: 2020/04/29].
2. Diabetes mortality and trends before 25 years of age: an analysis of the Global Burden of Disease Study 2019. Lancet Diabetes Endocrinol. 2022;10(3):177–92. https://doi.org/10.1016/s2213-8587(21)00349-1. [published Online First: 2022/02/11].
3. Wong ND, Sattar N. Cardiovascular risk in diabetes mellitus: epidemiology, assessment and prevention. Nat Reviews Cardiol. 2023;20(10):685–95. https://doi.org/10.1038/s41569-023-00877-z. [published Online First: 2023/05/17].
4. Mehta K, Goldin RF, Marchette D, et al. Neuronal classification from network connectivity via adjacency spectral embedding. Netw Neurosci (Cambridge Mass). 2021;5(3):689–710. doi: 10.1162/netn_a_00195 [published Online First: 2021/11/09].
5. Heather LC, Hafstad AD, Halade GV, et al. Guidelines on models of diabetic heart disease. Am J Physiol Heart Circ Physiol. 2022;323(1):H176–200. https://doi.org/10.1152/ajpheart.00058.2022. [published Online First: 2022/06/04].
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献